Quality of randomized clinical trials in juvenile idiopathic arthritis

Rheumatology

Volumn 47, Issue 5, 2008, Pages 640-645

  Abrahamyan, L ^a,b   Johnson, S R ^a,b   Beyene, J ^a,b   Shah, P S ^a,b   Feldman, Brian M ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Juvenile idiopathic arthritis; Quality; Randomized clinical trials; Systematic review

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; CALCIUM; FOLIC ACID; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; DIET SUPPLEMENTATION; DRUG INDUSTRY; EMBASE; FINANCIAL MANAGEMENT; FOLLOW UP; HUMAN; HYDROTHERAPY; INFORMATION PROCESSING; JUVENILE RHEUMATOID ARTHRITIS; MASSAGE; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; METHODOLOGY; ORTHOPEDIC SURGERY; ORTHOSIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SPLINTING; SYSTEMATIC REVIEW;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; TIME; TREATMENT OUTCOME;

EID: 42949151314     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem366     Document Type: Article

References (27)

1. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol 2002;29:1520-30.
2. Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA 2005;294:1671-84.
3. Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: A long-term follow-up study. Rheumatology 2000;39:198-204.
4. Minden K, Niewerth M, Listing J et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2392-401.
5. Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Functional outcome. Rheumatology 2002;41:1428-35.
6. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29:1989-99.
7. Guillaume S, Prieur AM, Coate J, Job-Deslandre C. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. Arthritis Rheum 2000;43:1858-65.
8. Oen K. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2002;16:347-60.
9. Minden K, Niewerth M, Listing J, Biedermann T, Schontube M, Zink A. Burden and cost of illness in patients with juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:836-42.
10. Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: A quality of life study. Arthritis Rheum 2003;48:767-75.
11. Lehman TJ. The future of pediatric rheumatology: Many questions remain. Arthritis Rheum 2007;56:2815-6.
12. Khan KS, Kunz R, Kleijnen J, Antes G. Systematic reviews to support evidence-based medicine: How to review and apply findings of healthcare research. Royal Society of Medicine Press, London (UK), 2003.
13. Altman DG. Better reporting of randomised controlled trials: The CONSORT statement. Br Med J 1996;313:570-1.
14. Baron G, Boutron I, Giraudeau B, Ravaud P. Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases. Arthritis Rheum 2005;52:1858-65.
15. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. Br Med J 2001;323:42-6.
16. Zulian F, Martini G, GGbber D, Agosto C, Gigante C, Zaochello F. Comparison of intra-articular triamcinolone hexacetonide and triamcinolone aoetonide in oligoarticular juvenile idiopathic arthritis. Rheumatology 2003;42:1254-9.
17. Makela AL, Lempiainen M, Yrjana T, Haapasaari J. Benorylate in the treatment of children with juvenile rheumatoid arthritis. Scand J Rheumatol Suppl 1979(25):1-7.
18. Gluud LL. Bias in clinical intervention research. Am J Epidemiol 2006;163:493-501.
19. Hill CL, LaValley MP, Felson DT. Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis Rheum 2002;46:779-84.
20. Karassa FB, Tatsioni A, Ioannidis JP. Design, quality, and bias in randomized controlled trials of systemic lupus orythematosus. J Rheumatol 2003;30:979-84.
21. Giannini EH, Ruperto N, Revelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
22. Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysts: The intention-to-treat principle. Med J Aust 2003; 179:438-40.
23. Schutz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
24. Moher D, Pham R, Jones A et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609-13.
25. Moher D, Pham B, Lawson ML, Klassen TP. The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess 2003;7:1-90.
26. Soares HP, Daniels S, Kumar A et al. Bad reporting does not mean bad methods for randomised trials: Observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. Br Med J 2004;328:22-4.
27. Huwiler-Muntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002;287:2801-4.